Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership339,298 shares
Latest Disclosed Value $ 151,510,129
Citadel Advisors Llc ownership in VRTX / Vertex Pharmaceuticals Incorporated

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 339,298 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $151,510,129 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 427,060 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -20.55% during the quarter. The current value of the position is $151,608,525 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 224,100 of underlying shares valued at $100,069,614 USD and put options representing 68,100 of underlying shares valued at $30,409,374 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 339,298 -87,762 -20.55 151,510 -21.75 0.0216
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 427,060 253,558 146.14 193,612 184.93 0.0291
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 173,502 144,675 501.87 67,950 429.49 0.0103
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 28,827 23,808 474.36 12,834 427.46 0.0022
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,019 -157,162 -96.91 2,433 -96.27 0.0005
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 162,181 111,949 222.86 65,310 179.57 0.0113
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 50,232 -54,363 -51.97 23,362 -52.35 0.0045
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 104,595 22,622 27.60 49,026 43.08 0.0099
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 81,973 -244,707 -74.91 34,266 -74.22 0.0066
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 326,680 298,936 1,077.48 132,923 1,277.86 0.0266
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 27,744 27,631 24,452.21 9,648 24,635.90 0.0021
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 113 -83,693 -99.87 40 -99.85 0.0000
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 83,806 -119,805 -58.84 26,405 -55.09 0.0058
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 203,611 189,846 1,379.19 58,799 1,375.11 0.0137
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 13,765 13,765 3,986 0.0009
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -42,605 -100.00 0 -100.00
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 42,605 -209,986 -83.13 11,119 -79.95 0.0023
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 252,591 -161,538 -39.01 55,469 -26.16 0.0113
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS Cmn 92532F100 414,129 24,539 6.30 75,119 -4.37 0.0156
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 389,590 -1,329,590 -77.34 78,553 -78.74 0.0176
2021-05-21 2021-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,719,180 240,821 16.29 369,435 5.74 0.0906
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,719,180 240,821 369,435 0.0906
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,478,359 566,347 62.10 349,395 40.78 0.0908
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 912,012 912,012 -38.31 248,177 -28.97 0.0704
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS Cmn 92532F100 0 -446,956 -100.00 0 -100.00
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS Cmn 92532F100 446,956 -583,879 -56.64 106,353 -52.88 0.0478
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS Cmn 92532F100 1,030,835 316,096 44.23 225,702 86.39 0.0979
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS Cmn 92532F100 714,739 573,869 407.37 121,091 368.75 0.0571
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS Cmn 92532F100 140,870 3,299 2.40 25,833 2.08 0.0118
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS Cmn 92532F100 137,571 -745,952 -84.43 25,306 -82.72 0.0126
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS Cmn 92532F100 883,523 54,690 6.60 146,409 -8.35 0.0802
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS Cmn 92532F100 828,833 -696,560 -45.66 159,749 -38.38 0.0716
2018-08-14 2018-06-30 13F/A-1 VERTEX PHARMACEUTICALS Cmn 92532F100 1,525,393 749,719 96.65 259,255 105.07 0.1282
2018-08-10 2018-06-30 13F VERTEX PHARMACEUTICALS Cmn 92532F100 1,525,393 749,719 259,255
2018-05-14 2018-03-31 13F/A-1 VERTEX PHARMACEUTICALS Cmn 92532F100 775,674 -938,586 -54.75 126,420 -50.79 0.0695
2018-05-11 2018-03-31 13F VERTEX PHARMACEUTICALS Cmn 92532F100 775,674 -938,586 126,420
2018-02-09 2017-12-31 13F VERTEX PHARMACEUTICALS Cmn 92532F100 1,714,260 366,651 27.21 256,898 25.38 0.1563
2017-11-09 2017-09-30 13F VERTEX PHARMACEUTICALS Cmn 92532F100 1,347,609 -277,444 -17.07 204,891 -2.16 0.1573
2017-08-11 2017-06-30 13F VERTEX PHARMACEUTICALS Cmn 92532F100 1,625,053 597,399 58.13 209,420 86.36 0.1774
2017-05-12 2017-03-31 13F VERTEX PHARMACEUTICALS Cmn 92532F100 1,027,654 993,845 2,939.59 112,374 4,411.20 0.1027
2017-02-10 2016-12-31 13F VERTEX PHARMACEUTICALS Cmn 92532F100 33,809 31,272 1,232.64 2,491 1,027.15 0.0025
2017-01-31 2016-09-30 13F/A-1 VERTEX PHARMACEUTICALS Cmn 92532F100 2,537 -52,617 -95.40 221 -95.34 0.0002
2016-11-10 2016-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 2,537 221
2017-01-31 2016-06-30 13F/A-1 VERTEX PHARMACEUTICALS Cmn 92532F100 55,154 -235,088 -81.00 4,744 -79.44 0.0053
2016-08-12 2016-06-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 55,154 4,744
2017-01-31 2016-03-31 13F/A-1 VERTEX PHARMACEUTICALS Cmn 92532F100 290,242 -418,244 -59.03 23,072 -74.12 0.0291
2016-05-13 2016-03-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 290,242 23,072
2017-01-31 2015-12-31 13F/A-1 VERTEX PHARMACEUTICALS Cmn 92532F100 708,486 -1,640,384 -69.84 89,148 -63.56 0.0973
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 708,486 89,148
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 2,348,870 1,899,809 423.06 244,611 341.14 0.2357
2015-08-14 2015-06-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 449,061 7,265 1.64 55,450 6.39 0.0486
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 441,796 -240,616 -35.26 52,119 -35.71 0.0580
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 682,412 561,776 465.68 81,071 498.35 0.0981
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 120,636 -108,163 -47.27 13,549 -37.45 0.0170
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 228,799 171,249 297.57 21,662 432.24 0.0293
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 57,550 -216,899 -79.03 4,070 -80.04 0.0056
2014-02-14 2013-12-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 274,449 263,062 2,310.20 20,391 2,260.07 0.0266
2013-11-14 2013-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn 92532F100 11,387 11,387 864 0.0013
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM Call 224,100 -9.78 100,070 -11.14 n/a n/a n/a
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM Call 248,400 -9.80 112,615 4.41 n/a n/a n/a
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM Call 275,400 -13.61 107,858 -24.01 n/a n/a n/a
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM Call 318,800 15.09 141,930 5.68 n/a n/a n/a
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM Call 277,000 -20.20 134,295 -3.92 n/a n/a n/a
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Call 347,100 65.68 139,777 43.46 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Call 209,500 54.73 97,434 53.53 n/a n/a n/a
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM Call 135,400 -9.13 63,465 1.90 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Call 149,000 -20.53 62,283 -18.36 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Call 187,500 33.17 76,292 55.82 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Call 140,800 26.39 48,962 24.89 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Call 111,400 -10.81 39,203 -0.38 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Call 124,900 -37.27 39,352 -31.56 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Call 199,100 -37.61 57,496 -37.77 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Call 319,100 -24.22 92,392 -22.14 n/a n/a n/a
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM Call 421,100 54.82 118,662 67.17 n/a n/a n/a
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM Call 272,000 -15.40 70,984 0.54 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Call 321,500 -7.64 70,601 11.81 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS Cmn Call 348,100 -37.14 63,142 -43.45 n/a n/a n/a
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM Call 553,800 158.06 111,663 142.14 n/a n/a n/a
2021-05-21 2021-03-31 13F/A VERTEX PHARMACEUTICALS COM Call 214,600 25.57 46,115 14.17 n/a n/a n/a
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM Call 214,600 46,115 n/a n/a n/a
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM Call 170,900 38.05 40,391 19.90 n/a n/a n/a
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM Call 123,800 -38.16 33,688 -42.04 n/a n/a n/a
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS Cmn Call 200,200 -4.12 58,120 16.98 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS Cmn Call 208,800 18.10 49,684 28.35 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS Cmn Call 176,800 60.44 38,710 107.34 n/a n/a n/a
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS Cmn Call 110,200 8.46 18,670 0.21 n/a n/a n/a
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS Cmn Call 101,600 26.37 18,631 25.97 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS Cmn Call 80,400 -19.52 14,790 -10.66 n/a n/a n/a
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS Cmn Call 99,900 -26.87 16,554 -37.12 n/a n/a n/a
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS Cmn Call 136,600 65.98 26,328 88.22 n/a n/a n/a
2018-08-14 2018-06-30 13F/A VERTEX PHARMACEUTICALS Cmn Call 82,300 68.99 13,988 76.24 n/a n/a n/a
2018-08-10 2018-06-30 13F VERTEX PHARMACEUTICALS Cmn Call 82,300 13,988 n/a n/a n/a
2018-05-14 2018-03-31 13F/A VERTEX PHARMACEUTICALS Cmn Call 48,700 -33.20 7,937 -27.35 n/a n/a n/a
2018-05-11 2018-03-31 13F VERTEX PHARMACEUTICALS Cmn Call 48,700 7,937 n/a n/a n/a
2018-02-09 2017-12-31 13F VERTEX PHARMACEUTICALS Cmn Call 72,900 -29.09 10,925 -30.10 n/a n/a n/a
2017-11-09 2017-09-30 13F VERTEX PHARMACEUTICALS Cmn Call 102,800 73.36 15,630 104.53 n/a n/a n/a
2017-08-11 2017-06-30 13F VERTEX PHARMACEUTICALS Cmn Call 59,300 -9.60 7,642 6.54 n/a n/a n/a
2017-05-12 2017-03-31 13F VERTEX PHARMACEUTICALS Cmn Call 65,600 0.15 7,173 48.66 n/a n/a n/a
2017-02-10 2016-12-31 13F VERTEX PHARMACEUTICALS Cmn Call 65,500 31.00 4,825 10.64 n/a n/a n/a
2017-01-31 2016-09-30 13F/A VERTEX PHARMACEUTICALS Cmn Call 50,000 -1.38 4,361 0.00 n/a n/a n/a
2016-11-10 2016-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 50,000 4,361 n/a n/a n/a
2017-01-31 2016-06-30 13F/A VERTEX PHARMACEUTICALS Cmn Call 50,700 -0.20 4,361 8.00 n/a n/a n/a
2016-08-12 2016-06-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 50,700 4,361 n/a n/a n/a
2017-01-31 2016-03-31 13F/A VERTEX PHARMACEUTICALS Cmn Call 50,800 18.14 4,038 -25.37 n/a n/a n/a
2016-05-13 2016-03-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 50,800 4,038 n/a n/a n/a
2017-01-31 2015-12-31 13F/A VERTEX PHARMACEUTICALS Cmn Call 43,000 -27.97 5,411 -12.96 n/a n/a n/a
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 43,000 5,411 n/a n/a n/a
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 59,700 25.42 6,217 5.77 n/a n/a n/a
2015-08-14 2015-06-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 47,600 -1.65 5,878 2.94 n/a n/a n/a
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 48,400 -54.38 5,710 -54.70 n/a n/a n/a
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 106,100 -4.76 12,605 0.75 n/a n/a n/a
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 111,400 -25.63 12,511 -11.79 n/a n/a n/a
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 149,800 -7.53 14,183 23.79 n/a n/a n/a
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 162,000 -0.98 11,457 -5.74 n/a n/a n/a
2014-02-14 2013-12-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 163,600 43.26 12,155 40.37 n/a n/a n/a
2013-11-14 2013-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Call 114,200 49.28 8,659 41.72 n/a n/a n/a
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS Cmn Call 76,500 6,110 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM Put 68,100 -40.52 30,409 -41.42 n/a n/a n/a
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM Put 114,500 -15.81 51,910 -2.54 n/a n/a n/a
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM Put 136,000 8.71 53,263 -4.36 n/a n/a n/a
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM Put 125,100 19.83 55,695 10.03 n/a n/a n/a
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM Put 104,400 -39.23 50,615 -26.84 n/a n/a n/a
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Put 171,800 82.38 69,184 57.92 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Put 94,200 -16.04 43,811 -16.70 n/a n/a n/a
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM Put 112,200 -23.26 52,590 -13.95 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Put 146,200 7.58 61,113 10.52 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Put 135,900 -0.95 55,296 15.90 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Put 137,200 39.43 47,710 37.78 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Put 98,400 -36.23 34,628 -28.77 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Put 154,300 -18.49 48,615 -11.07 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Put 189,300 -15.79 54,666 -16.01 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Put 224,800 -22.43 65,088 -20.30 n/a n/a n/a
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM Put 289,800 -37.68 81,662 -32.71 n/a n/a n/a
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM Put 465,000 85.48 121,351 120.43 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Put 250,700 -19.65 55,053 -2.72 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS Cmn Put 312,000 -53.10 56,594 -57.81 n/a n/a n/a
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM Put 665,300 120.01 134,144 106.43 n/a n/a n/a
2021-05-21 2021-03-31 13F/A VERTEX PHARMACEUTICALS COM Put 302,400 70.17 64,983 54.73 n/a n/a n/a
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM Put 302,400 64,983 n/a n/a n/a
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM Put 177,700 0.68 41,998 -12.56 n/a n/a n/a
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM Put 176,500 -15.14 48,029 -20.46 n/a n/a n/a
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS Cmn Put 208,000 78.23 60,384 117.45 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS Cmn Put 116,700 -38.02 27,769 -32.65 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS Cmn Put 188,300 104.90 41,228 164.79 n/a n/a n/a
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS Cmn Put 91,900 -0.43 15,570 -8.01 n/a n/a n/a
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS Cmn Put 92,300 53.32 16,926 52.84 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS Cmn Put 60,200 -71.28 11,074 -68.12 n/a n/a n/a
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS Cmn Put 209,600 137.10 34,733 103.86 n/a n/a n/a
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS Cmn Put 88,400 -15.00 17,038 -3.61 n/a n/a n/a
2018-08-14 2018-06-30 13F/A VERTEX PHARMACEUTICALS Cmn Put 104,000 113.11 17,676 122.26 n/a n/a n/a
2018-08-10 2018-06-30 13F VERTEX PHARMACEUTICALS Cmn Put 104,000 17,676 n/a n/a n/a
2018-05-14 2018-03-31 13F/A VERTEX PHARMACEUTICALS Cmn Put 48,800 -51.30 7,953 -47.04 n/a n/a n/a
2018-05-11 2018-03-31 13F VERTEX PHARMACEUTICALS Cmn Put 48,800 7,953 n/a n/a n/a
2018-02-09 2017-12-31 13F VERTEX PHARMACEUTICALS Cmn Put 100,200 -17.53 15,016 -18.71 n/a n/a n/a
2017-11-09 2017-09-30 13F VERTEX PHARMACEUTICALS Cmn Put 121,500 178.67 18,473 228.76 n/a n/a n/a
2017-08-11 2017-06-30 13F VERTEX PHARMACEUTICALS Cmn Put 43,600 -1.13 5,619 16.53 n/a n/a n/a
2017-05-12 2017-03-31 13F VERTEX PHARMACEUTICALS Cmn Put 44,100 17.29 4,822 74.08 n/a n/a n/a
2017-02-10 2016-12-31 13F VERTEX PHARMACEUTICALS Cmn Put 37,600 -18.08 2,770 -30.80 n/a n/a n/a
2017-01-31 2016-09-30 13F/A VERTEX PHARMACEUTICALS Cmn Put 45,900 59.93 4,003 62.13 n/a n/a n/a
2016-11-10 2016-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 45,900 4,003 n/a n/a n/a
2017-01-31 2016-06-30 13F/A VERTEX PHARMACEUTICALS Cmn Put 28,700 -24.47 2,469 -18.27 n/a n/a n/a
2016-08-12 2016-06-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 28,700 2,469 n/a n/a n/a
2017-01-31 2016-03-31 13F/A VERTEX PHARMACEUTICALS Cmn Put 38,000 41.79 3,021 -10.41 n/a n/a n/a
2016-05-13 2016-03-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 38,000 3,021 n/a n/a n/a
2017-01-31 2015-12-31 13F/A VERTEX PHARMACEUTICALS Cmn Put 26,800 -43.10 3,372 -31.25 n/a n/a n/a
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 26,800 3,372 n/a n/a n/a
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 47,100 -68.49 4,905 -73.43 n/a n/a n/a
2015-08-14 2015-06-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 149,500 166.01 18,461 178.45 n/a n/a n/a
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 56,200 -39.70 6,630 -40.12 n/a n/a n/a
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 93,200 -7.63 11,072 -2.29 n/a n/a n/a
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 100,900 -46.61 11,332 -36.68 n/a n/a n/a
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 189,000 20.23 17,895 60.97 n/a n/a n/a
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 157,200 -12.28 11,117 -16.51 n/a n/a n/a
2014-02-14 2013-12-31 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 179,200 111.82 13,315 107.59 n/a n/a n/a
2013-11-14 2013-09-30 13F VERTEX PHARMACEUTICALS INC CMN STK Cmn Put 84,600 -6.62 6,414 -11.36 n/a n/a n/a
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS Cmn Put 90,600 7,236 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.